用于Nutlin-3a眼部输送的微流体制造型脂质体作为增殖性视网膜疾病治疗的潜在候选者

Elisabetta Esposito1, Elena Pozza2, Catia Contado1

  • 1Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, I-44121, Italy.

概括

这项研究探讨了Nutlin-3a,一种MDM2/p53抑制剂,用于扩散性玻璃关节疾病. 脂质体有效地将Nutlin-3a传递给视网膜色素上皮细胞,降低了活力和迁移.